Dr. Ajit Singh is a partner at Artiman Ventures, a Silicon Valley VC firm focused on early-stage technology and life science investments. He also serves on the board of Trustees of the American Association for Cancer Research (AACR) Foundation and is an Adjunct Professor in the School of Medicine at Stanford. He is on the Board of Directors of Visby Medical, CORE Diagnostics, Cadila Pharmaceuticals, Summer Bio and Sofie Biosciences, and is a Senior Advisor to the Tata Trusts Cancer Care program.
In the past he has served as the CEO of Siemens Oncology and the CEO of BioImagene, a cancer diagnostics startup that was acquired by Roche. Ajit has a Ph.D. in Computer Science from Columbia University, a Master’s in Computer Engineering from Syracuse University and a bachelor’s in Electrical Engineering from Banaras Hindu University. He has published two books and five patents.
